RARE
Ultragenyx
14.50$
+12.6%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | 137,747.4% | 0.0% | 2.2% | 8.7% | 2.3% | 4.6% | 7.8% | 10.4% | 13.7% | 16.2% | |
| – | – | 100.0% | 100.0% | 97.8% | 91.3% | 97.7% | 95.4% | 92.2% | 89.6% | 86.3% | 83.8% | |
| – | – | 137,747.4% | 8,868.5% | 570.9% | 344.6% | 152.0% | 141.5% | 194.3% | 149.3% | 124.6% | 111.4% | |
| – | – | 48,824.1% | 3,825.0% | 248.0% | 155.7% | 67.5% | 62.6% | 76.6% | 71.3% | 57.4% | 51.9% | |
| – | – | 186,571.4% | 12,693.5% | 819.0% | 500.3% | 219.5% | 204.1% | 270.8% | 220.7% | 182.0% | 163.3% | |
| – | – | -186,471.4% | -12,593.5% | -721.2% | -409.0% | -121.8% | -108.6% | -178.6% | -131.1% | -95.7% | -79.5% | |
| – | – | 0.0% | 0.0% | 0.0% | 1.1% | 12.3% | 8.4% | 11.8% | 15.2% | 11.3% | 9.2% | |
| – | – | -184,841.4% | -12,187.5% | -382.7% | -385.1% | -68.4% | -128.9% | -193.1% | -140.1% | -101.3% | -84.8% | |
| – | – | 26.3% | -620.2% | 1.0% | 3.2% | 0.4% | 0.3% | 1.6% | -0.4% | 0.3% | 0.6% | |
| – | – | -184,867.7% | -11,567.3% | -383.7% | -388.3% | -68.8% | -129.2% | -194.7% | -139.7% | -101.6% | -85.4% | |
| – | – | -183,897.0% | -12,370.5% | -344.8% | -375.8% | -51.6% | -116.8% | -176.3% | -118.9% | -83.7% | -70.4% |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.